Galderma stock: CFO exit and December vote reshape governance

Published on 11/05/2026 at 18:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Galderma stock traded at 213.30 euros on Lang & Schwarz at 18:05 CET on November 5, 2026. A CFO exit and December board vote are next.

Governance changes set next steps

Luigi La Corte will leave Galderma after a transition period, while succession details remain pending.
Shareholders will vote on two proposed directors and a larger board at the extraordinary meeting on December 3.
The April annual meeting approved a gross dividend and Galderma's 2025 financial and non-financial reports.

Galderma, CH1335392721, Illustration mit AI erstellt.

Galderma announced on Monday, November 2, 2026, that Chief Financial Officer Luigi La Corte will leave the company to pursue a new opportunity. He will remain in the role during a transition period, while the company prepares further details on the succession process, according to Ad Hoc News.

Board proposals go to shareholders

Galderma has nominated Rosalind Brewer and Petra Rumpf as new directors. Shareholders will consider their appointments at a virtual extraordinary general meeting on December 3, 2026, at 14:00 CET. The agenda also proposes increasing the maximum board size from 10 to 11 members.

Sherilyn McCoy is expected to leave the board after seven years because of conflicting obligations. Galderma has also proposed Brewer for individual election to the Compensation Committee. The company has not yet named La Corte's successor or provided a detailed handover timetable, leaving the December vote and a later succession update as the next governance milestones.

AGM decisions provide background

The earlier Annual General Meeting on April 22, 2026, approved a gross dividend of 0.35 Swiss francs per dividend-bearing share and elected Harry Kirsch as an independent director. Samuel du Retail and Delphine Viguier-Hovasse, representatives of L'Oreal, joined as non-independent directors. The meeting also approved Galderma's 2025 annual financial statements, non-financial report and compensation report, according to the company's April 22 press release.

Galderma stock traded at 213.30 euros on Lang & Schwarz at 18:05 CET on Thursday, November 5, 2026. Investors can follow the real-time quote of Galderma stock.